Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Classement en actions #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Prix de l'action
$11.14
Dernière synchronisation: 2023-11-28
Capitalisation boursière
$160.14M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Monterey Bio Acquisition Corporation (MTRY)
Historique du rendement du dividende pour Monterey Bio Acquisition Corporation (MTRY)
Le rendement du dividende (TTM) de Monterey Bio Acquisition Corporation (symbole boursier : MTRY) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Monterey Bio Acquisition Corporation (MTRY) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes